trending Market Intelligence /marketintelligence/en/news-insights/trending/_gi9mp8hnldw5trgcow5rw2 content esgSubNav
In This List

Tetraphase Pharmaceuticals CFO resigns

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Tetraphase Pharmaceuticals CFO resigns

Tetraphase Pharmaceuticals Inc. said Kamalam Unninayar resigned as CFO on March 16.

Unninayar joined the Watertown, Mass.-based antibiotics developer in October 2017.

Senior Vice President of Finance Christopher Watt will act as principal financial officer and principal accounting officer until a replacement CFO is named, Tetraphase said in a filing.